220 related articles for article (PubMed ID: 22001891)
1. HIV and hepatitis C co-infection: acute HCV therapy.
Boesecke C; Vogel M
Curr Opin HIV AIDS; 2011 Nov; 6(6):459-64. PubMed ID: 22001891
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute hepatitis C infection in HIV-infected patients.
Boesecke C; Rockstroh JK
Curr Opin HIV AIDS; 2011 Jul; 6(4):278-84. PubMed ID: 21519248
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatitis C in patients with HIV.
Boesecke C; Rockstroh JK
Semin Liver Dis; 2012 May; 32(2):130-7. PubMed ID: 22760652
[TBL] [Abstract][Full Text] [Related]
4. Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
Martin-Carbonero L; Nuñez M; Mariño A; Alcocer F; Bonet L; García-Samaniego J; López-Serrano P; Cordero M; Portu J; Soriano V
AIDS; 2008 Jan; 22(1):15-21. PubMed ID: 18090387
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort.
Vogel M; Dominguez S; Bhagani S; Azwa A; Page E; Guiguet M; Valantin MA; Katlama C; Rockstroh JK; Nelson M
Antivir Ther; 2010; 15(2):267-79. PubMed ID: 20386082
[TBL] [Abstract][Full Text] [Related]
6. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
Ramos B; Núñez M; Rendón A; Berdún MA; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola JM; Garcia-Samaniego J; Soriano V
J Viral Hepat; 2007 Jun; 14(6):387-91. PubMed ID: 17501758
[TBL] [Abstract][Full Text] [Related]
7. Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome.
Boesecke C; Ingiliz P; Reiberger T; Stellbrink HJ; Bhagani S; Page E; Mauss S; Lutz T; Voigt E; Guiguet M; Valantin MA; Baumgarten A; Nelson M; Vogel M; Rockstroh JK;
Infection; 2016 Feb; 44(1):93-101. PubMed ID: 26481253
[TBL] [Abstract][Full Text] [Related]
8. OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients.
Carosi G; Bruno R; Cariti G; Nasta P; Gulminetti R; Galli M; Angarano G; Verucchi G; Pontali E; Capetti A; Raise E; Ravasio V; Maida I; Iannacone C; Caputo A; Puoti M
Antivir Ther; 2014; 19(8):735-45. PubMed ID: 24583976
[TBL] [Abstract][Full Text] [Related]
9. Role of rapid virological response in prediction of sustained virological response to Peg-IFN plus ribavirin in HCV / HIV co-infected individuals.
Shea DO; Tuite H; Farrell G; Codd M; Mulcahy F; Norris S; Bergin C
J Viral Hepat; 2008 Jul; 15(7):482-9. PubMed ID: 18221297
[TBL] [Abstract][Full Text] [Related]
10. [Outcome of treatment with peg-interferon and ribavirin in HIV-HCV co-infected patients: "real life" single center experience].
Veitsman E; Shahar E; Hassoun G; Lorber M; Kramskay R; Maor C; Pollack S; Baruch Y
Harefuah; 2012 Dec; 151(12):684-7, 721, 720. PubMed ID: 23330260
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon-alfa mono-therapy in the treatment of acute hepatitis C in HIV-infection.
Boesecke C; van Assen S; Stellbrink HJ; Baumgarten A; Ingiliz P; Strassburg CP; Schwarze-Zander C; Wasmuth JC; Hoepelman AI; Rockstroh JK; Arends JE
J Viral Hepat; 2014 Nov; 21(11):780-5. PubMed ID: 25040149
[TBL] [Abstract][Full Text] [Related]
12. Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.
Nasta P; Maida I; Cattelan AM; Pontali E; Angeli E; Giralda M; Verucchi G; Caputo A; Iannacone C; Puoti M; Carosi G
J Womens Health (Larchmt); 2015 Feb; 24(2):159-64. PubMed ID: 25682817
[TBL] [Abstract][Full Text] [Related]
13. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy.
Bruno R; Cariti G; Nasta P; Capetti A; Ravasio V; Galli M; Raise E; Palmieri G; Iannacone C; Puoti M
Liver Int; 2015 Jan; 35(1):120-9. PubMed ID: 25041136
[TBL] [Abstract][Full Text] [Related]
14. Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin.
Bonardi R; Tabone M; Manca A; Pellicano R; Ciancio A; Rizzetto M
Biomed Pharmacother; 2011 Jul; 65(4):303-6. PubMed ID: 21723079
[TBL] [Abstract][Full Text] [Related]
15. Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.
Tural C; Galeras JA; Planas R; Coll S; Sirera G; Giménez D; Salas A; Rey-Joly C; Cirera I; Márquez C; Tor J; Videla S; García-Retortillo M; Clotet B; Solà R
Antivir Ther; 2008; 13(8):1047-55. PubMed ID: 19195330
[TBL] [Abstract][Full Text] [Related]
16. Delaying HCV treatment in HIV-positive patients.
Carter M
IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
[No Abstract] [Full Text] [Related]
17. Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study.
Milazzo L; Caramma I; Mazzali C; Cesari M; Olivetti M; Galli M; Antinori S
J Antimicrob Chemother; 2010 Apr; 65(4):735-40. PubMed ID: 20118492
[TBL] [Abstract][Full Text] [Related]
18. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy.
Murata M; Furusyo N; Ogawa E; Mitsumoto F; Hiramine S; Ikezaki H; Takayama K; Shimizu M; Toyoda K; Kainuma M; Hayashi J
J Infect Chemother; 2014 May; 20(5):320-4. PubMed ID: 24477330
[TBL] [Abstract][Full Text] [Related]
19. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
[TBL] [Abstract][Full Text] [Related]
20. Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.
Labarga P; Barreiro P; da Silva A; Guardiola JM; Rubio R; Aguirrebengoa K; Miralles P; Portu J; Téllez MJ; Morano L; Castro A; Pineda JA; Terrón A; Hernández-Quero J; Mariño A; Ríos MJ; Echeverría S; Asensi V; Vispo E; Soriano V;
J Infect Dis; 2012 Sep; 206(6):961-8. PubMed ID: 22807523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
